Healthscope announces refreshed AU$4.5bn takeover bid from Brookfield

By Sarah Smith

Australian healthcare operator Healthscope announced on 12 November that it has received a fresh takeover bid from Canadian asset management firm Brookfield 

The off-market offer of AU$2.455 per share, with a simultaneous scheme of arrangement of $2.55 per share, equates to a total deal value of $4.5bn, superseding a $4.1bn offer made by BGH Capital and its partners in October.

Healthscope rejected bids from both firms in May this year, with Brookfield offering $4.35bn and BGH offering $4.1bn.

The firm said in its statement that it will not provide due diligence access to the BGH Capital-AustralianSuper consortium because Brookfield’s offer is considerably more attractive.

Brookfield has thus been granted exclusive due diligence for a limited time in order to enact a binding offer.

See more:

 

Healthscope added in its statement that it has returned to growth, with projections of double-digit earnings growth for FY19.

Paula Dwyer, Chairman of Healthscope, said in the statement:

“We consider the Brookfield Proposal to be attractive to shareholders. It is superior to the BGH-AustralianSuper proposal and provides enhanced certainty.

“It also offers more options for Healthscope shareholders, including an option to retain an equity exposure to an unlisted Healthscope.”

Share

Featured Videos

View all
Featured

Schneider Electric - Global Specialist in Energy Management

Digital Strategy

Allianz Malaysia: Closer to customers through digital